Virtus LifeSci Performance

Virtus LifeSci Biotech Clinical Trls ETF -- USA Etf  

USD 31.81  0.13  0.41%

The entity has beta of -0.1041 which indicates as returns on market increase, returns on owning Virtus LifeSci are expected to decrease at a much smaller rate. During bear market, Virtus LifeSci is likely to outperform the market.. Even though it is essential to pay attention to Virtus LifeSci Biotech current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any etf is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Virtus LifeSci Biotech Clinical Trls ETF exposes twenty-eight different technical indicators which can help you to evaluate its performance.
 Time Horizon     30 Days    Login   to change

Virtus LifeSci Biotech Relative Risk vs. Return Landscape

If you would invest  3,291  in Virtus LifeSci Biotech Clinical Trls ETF on March 21, 2018 and sell it today you would lose (97.00)  from holding Virtus LifeSci Biotech Clinical Trls ETF or give up 2.95% of portfolio value over 30 days. Virtus LifeSci Biotech Clinical Trls ETF is generating negative expected returns assuming volatility of 2.3282% on return distribution over 30 days investment horizon. In other words, 21% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering 30-days investment horizon, Virtus LifeSci Biotech Clinical Trls ETF is expected to under-perform the market. In addition to that, the company is 1.65 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.01 per unit of volatility.

Performance Rating

Virtus LifeSci Biotech Clinical Trls ETF Risk Adjusted Performance Analysis
0 

Risk-Adjusted Performance

Over the last 30 days Virtus LifeSci Biotech Clinical Trls ETF has generated negative risk-adjusted returns adding no value to investors with long positions.

2 Months Efficiency

Virtus LifeSci Sharpe Ratio = -0.0184
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsBBC
Estimated Market Risk
 2.33
  actual daily
 
 79 %
of total potential
  
Expected Return
 -0.04
  actual daily
 
 1 %
of total potential
  
Risk-Adjusted Return
 -0.02
  actual daily
 
 1 %
of total potential
  
Based on monthly moving average Virtus LifeSci is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virtus LifeSci by adding it to a well-diversified portfolio.

Dividends

Virtus LifeSci Biotech Dividends Analysis
Check Virtus LifeSci Biotech dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Check also Trending Equities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.